Re: Equity offering

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Polar one

Rank: Mail Room [?]

Points: 147 [?]

Votes: 7 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Equity offering

in response to

Re: Equity offering

tada

posted on Jun 06, 2018 01:49PM

Shares on the market for $2.50 US hope to raise $10,000,000.

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply